Do Opioid Addicts Require Higher Doses of Heparin During Percutaneous Coronary Intervention?

Tahereh Afaghnia1, Mohammad Nasim-Tajik2, Elham Boushehri3

  • 1Student Research Committee, School of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Addiction & Health
|February 18, 2022
PubMed

Insights

Opioid addicts showed lower activated clotting time (ACT) during percutaneous coronary intervention (PCI) despite receiving standard heparin doses. This suggests opioid users may need increased heparin for effective anticoagulation during PCI.

Area of Science:

  • Cardiology
  • Pharmacology
  • Addiction Medicine

Background:

  • Percutaneous coronary intervention (PCI) necessitates anticoagulation, typically with heparin, to prevent thrombotic events.
  • Opioid addiction may alter heparin's efficacy, potentially requiring dose adjustments during PCI procedures.

Purpose of the Study:

  • To compare the effect of a standard heparin dose on activated clotting time (ACT) in opioid addicts versus non-addicts undergoing PCI.
  • To investigate potential differences in anticoagulation response between these patient groups.

Main Methods:

  • A comparative study involving 107 patients (50 opioid addicts, 57 non-addicts) scheduled for elective PCI.
  • Standard heparin administration (100 IU/kg) at procedure start, with ACT measurements at 2 and 30 minutes.
  • Baseline characteristics and coagulation parameters (PT, PTT, INR, platelet count) were recorded.

Main Results:

  • Opioid addicts exhibited significantly lower ACT levels at both 2 and 30 minutes post-heparin administration compared to non-addicts.
  • While hyperlipidemia was more prevalent in non-addicts and smoking in opioid addicts, baseline coagulation tests and heparin dosage were similar.
  • ACT at 2 minutes correlated with aspirin use in opioid addicts and inversely with smoking in non-addicts.

Conclusions:

  • Opioid addicts demonstrate a diminished response to standard heparin dosing during PCI, indicated by lower ACT.
  • These findings suggest that opioid-addicted patients may require higher heparin doses to achieve adequate anticoagulation and prevent thrombotic complications during PCI.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
975
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
477
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
423
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
883
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
227
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
44